Chun‐Bo Teng

2.7k total citations · 1 hit paper
62 papers, 2.2k citations indexed

About

Chun‐Bo Teng is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Chun‐Bo Teng has authored 62 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 20 papers in Cancer Research and 15 papers in Surgery. Recurrent topics in Chun‐Bo Teng's work include MicroRNA in disease regulation (18 papers), Pancreatic function and diabetes (15 papers) and Cancer-related molecular mechanisms research (9 papers). Chun‐Bo Teng is often cited by papers focused on MicroRNA in disease regulation (18 papers), Pancreatic function and diabetes (15 papers) and Cancer-related molecular mechanisms research (9 papers). Chun‐Bo Teng collaborates with scholars based in China, United States and Germany. Chun‐Bo Teng's co-authors include Haipeng Yu, Zhanhu Guo, Hu Liu, Shouxin Liu, Houjuan Qi, Mei He, Yunchao Li, Yicheng Zhao, Qiang Gao and Miao Liu and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and PLoS ONE.

In The Last Decade

Chun‐Bo Teng

62 papers receiving 2.2k citations

Hit Papers

Biomass-derived nitrogen-doped carbon quantum dots: highl... 2018 2026 2020 2023 2018 100 200 300 400 500

Peers

Chun‐Bo Teng
An Hong China
Chun‐Bo Teng
Citations per year, relative to Chun‐Bo Teng Chun‐Bo Teng (= 1×) peers An Hong

Countries citing papers authored by Chun‐Bo Teng

Since Specialization
Citations

This map shows the geographic impact of Chun‐Bo Teng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chun‐Bo Teng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chun‐Bo Teng more than expected).

Fields of papers citing papers by Chun‐Bo Teng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chun‐Bo Teng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chun‐Bo Teng. The network helps show where Chun‐Bo Teng may publish in the future.

Co-authorship network of co-authors of Chun‐Bo Teng

This figure shows the co-authorship network connecting the top 25 collaborators of Chun‐Bo Teng. A scholar is included among the top collaborators of Chun‐Bo Teng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chun‐Bo Teng. Chun‐Bo Teng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Tianyang, et al.. (2025). The impact of aflatoxin B1 on animal health: Metabolic processes, detection methods, and preventive measures. Toxicon. 255. 108262–108262. 3 indexed citations
2.
Wang, Jiaru, Hai‐Fan Yu, Jing Jin, et al.. (2025). Copper is essential for cyclin B1-mediated CDK1 activation. Nature Communications. 16(1). 2288–2288. 7 indexed citations
3.
Yu, Hai‐Fan, Qing‐Yin Zeng, Ping Yue, et al.. (2024). Hippo-YAP signaling alleviates copper-induced mitochondrial dysfunction and oxidative damage via the ATOX1-PPA2 pathway. International Journal of Biological Macromolecules. 290. 138908–138908. 1 indexed citations
4.
Wang, Wenmeng, Guangyue Li, Jiahui Cheng, et al.. (2022). A histidine cluster determines YY1-compartmentalized coactivators and chromatin elements in phase-separated enhancer clusters. Nucleic Acids Research. 50(9). 4917–4937. 57 indexed citations
5.
Jiang, Di, et al.. (2022). MiR-18 inhibitor promotes the differentiation of bovine skeletal muscle-derived satellite cells by increasing MEF2D expression. Journal of Animal Science. 100(11). 1 indexed citations
6.
Yu, Wen, et al.. (2022). A saponin from astragalus promotes pancreatic ductal organoids differentiation into insulin-producing cells. Phytomedicine. 102. 154190–154190. 8 indexed citations
7.
Jin, Jing, Mingjun Ma, Jiaru Wang, et al.. (2022). Copper enhances genotoxic drug resistance via ATOX1 activated DNA damage repair. Cancer Letters. 536. 215651–215651. 43 indexed citations
8.
Yang, Lin, Delin Kong, Mei He, et al.. (2020). MiR-7 mediates mitochondrial impairment to trigger apoptosis and necroptosis in Rhabdomyosarcoma. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1867(12). 118826–118826. 28 indexed citations
9.
Guo, Jiamin, Jing Song, Yi Pan, et al.. (2019). Expansion and Maintenance of CD133-Expressing Pancreatic Ductal Epithelial Cells by Inhibition of TGF-β Signaling. Stem Cells and Development. 28(18). 1236–1252. 4 indexed citations
10.
Zhang, Zhenwu, Jie Liang, Mingjun Ma, et al.. (2018). Mutual inhibitions between epidermal growth factor receptor signaling and miR‐124a control pancreatic progenitor proliferation. Journal of Cellular Physiology. 234(8). 12978–12988. 3 indexed citations
11.
Qi, Houjuan, Min Teng, Miao Liu, et al.. (2018). Biomass-derived nitrogen-doped carbon quantum dots: highly selective fluorescent probe for detecting Fe3+ ions and tetracyclines. Journal of Colloid and Interface Science. 539. 332–341. 537 indexed citations breakdown →
12.
Zhao, Yicheng, Yuanyuan Song, Yao Li, Guangqi Song, & Chun‐Bo Teng. (2017). Circulating microRNAs: Promising Biomarkers Involved in Several Cancers and Other Diseases. DNA and Cell Biology. 36(2). 77–94. 44 indexed citations
13.
Li, Yunchao & Chun‐Bo Teng. (2014). Angiopoietin-like proteins 3, 4 and 8: regulating lipid metabolism and providing new hope for metabolic syndrome. Journal of drug targeting. 22(8). 679–687. 59 indexed citations
14.
Kong, Delin, et al.. (2014). Hippo signaling pathway in liver and pancreas: the potential drug target for tumor therapy. Journal of drug targeting. 23(2). 125–133. 14 indexed citations
15.
Zhao, Yicheng, Zhen Dai, Liang Huai Yang, et al.. (2014). Sequence-specific inhibition of microRNA via CRISPR/CRISPRi system. Scientific Reports. 4(1). 3943–3943. 85 indexed citations
16.
Zhang, Zhenwu, et al.. (2013). miR-375 Inhibits Proliferation of Mouse Pancreatic Progenitor Cells by Targeting YAP1. Cellular Physiology and Biochemistry. 32(6). 1808–1817. 53 indexed citations
17.
Zhang, Zhenwu, et al.. (2013). Complete disassociation of adult pancreas into viable single cells through cold trypsin-EDTA digestion. Journal of Zhejiang University SCIENCE B. 14(7). 596–603. 6 indexed citations
18.
Teng, Chun‐Bo, et al.. (2013). Regulation of differentiation of mesenchymal stem cells by the Hippo pathway effectors TAZ/YAP. Hereditas (Beijing). 35(11). 1283–1290. 9 indexed citations
19.
Fan, Heng‐Yu, Chao Tong, Chun‐Bo Teng, et al.. (2003). Characterization of polo‐like kinase‐1 in rat oocytes and early embryos implies its functional roles in the regulation of meiotic maturation, fertilization, and cleavage. Molecular Reproduction and Development. 65(3). 318–329. 24 indexed citations
20.
Ding, Nai‐Zheng, Chun‐Bo Teng, Hong Ma, et al.. (2003). Peroxisome proliferator‐activated receptor delta expression and regulation in mouse uterus during embryo implantation and decidualization. Molecular Reproduction and Development. 66(3). 218–224. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026